RecruitingPhase 2Other
Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT)
Sponsored by University of Cincinnati
NCT ID
NCT05337618
Target Enrollment
72 participants
Start Date
2022-12-16
Est. Completion
2027-03-20
About This Study
This study is a randomized Phase 2 trial to determine the feasibility of real-time electrocorticographic monitoring of spreading depolarizations (SD) to guide implementation of a tier-based protocol of intensive care therapies, aimed at SD suppression, for the management of patients who have undergone acute operative treatment of severe traumatic brain injury.
Conditions Studied
Interventions
- •Full-band Electrocorticography
- •Treatment Algorithm
Eligibility
Age:18 Years - 80 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: (1) clinical indication for emergency craniotomy with dural opening to treat acute TBI within 72 hr post-trauma Exclusion Criteria: 1. persistent bilateral non-reactive pupils or other evidence of non-survivable injury, 2. decompressive craniectomy to treat refractory ICP subsequent to diffuse injury, (3) co-enrollment in another therapeutic TBI trial, and (4) pregnancy
Study Locations (1)
University of Cincinnati
Cincinnati, Ohio, United States